Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Matthew Arnold

 
 

Recent Articles

M3 lands ex-Epocrates research head, others

May 01, 2013

Athenahealth has wasted little time in putting its mark on Epocrates
 

Weber Shandwick goes high science with specialty shop

May 01, 2013

Weber Shandwick is launching a high-science shop, dubbed Element Scientific Communications
 

Agency Business briefs: May 2013

May 01, 2013

News on Saatchi & Saatchi Wellness, Omincom, Ogilvy CommonHealth, WholeView and ApotheCom Group
 

Headliner: Mike Kaufmann, Cardinal Health

May 01, 2013

Mike Kaufman, Executive sponsor, Women's Initiative Network, Cardinal Health
 

White House budget would cost pharmas

May 01, 2013

The White House has released its proposed budget for the 2014 fiscal year, and while it gives a modest boost to Health and Human Services, it also seeks to extract more cost savings from pharmas.
 

Fabry film spotlights a rare disease

April 30, 2013

Genzyme is taking rare disease awareness to another level with a documentary film, dubbed "Facing Fabry Together," that follows four families grappling with the genetic disorder.
 

Pharmas to biotechs: let's make a deal

April 25, 2013

Having finally accepted that external R&D is the future, big pharmas are snapping up earlier-stage biotechs and biologics, but they're not betting the farm on them, thanks to pre-nup-like earnout deals.
 

Q&A: BIO's Jim Greenwood

April 22, 2013

BIO chief Jim Greenwood talks policy priorities and previews the group's International Convention, now underway in Chicago.
 

Qsymia gets a boost, but weight loss remains anyone's game

April 16, 2013

Vivus got a much-needed green light to expand its marketing of Qsymia, but drug stores aren't the solution to all its problems in what's shaping up to be a very competitive category.
 

Myriad decision could be a drag on personalized medicine R&D

April 15, 2013

After a skeptical Supreme Court hearing, diagnostics and biopharma patent lawyers are sweating the outcome of Association for Molecular Pathology vs. Myriad Genetics, in which the Court could decide whether or not swatches of genes are patentable.
 
  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Accountable Care Organizations Acquisition Adherence Advertising App Cardiovascular Clinical Trial Diabetes FDA Generic Generic Drugs Health Affairs Healthcare Reform Journal Articles Layoffs Mobile Obesity Oncology OPDP Patent Cliff Patents Research & Development Rheumatology Social Media Women's Health

Topics

Consumer
Continuing Medical Education (CME)
Digital
Direct to Consumer
Direct to Patient
Downsize
Education & Awareness
FDA
Label
Legal
Online
Over the Counter
Promotion
Public Relations
Sales Force
Trend

Sectors

Agency
Biotech
Government
Media
Pharmaceutical
Suppliers & Vendors

Verticals

Business
Marketing & Communications
Regulatory
Research & Development

Events

Awards

Archives

Issue Archive
Sitemap
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions